Custom-Made Device (Device Made Specifically for an Individual): Definition, Annex XIII Statement and ITC Registration in ÜTS

SUMMARY
A custom-made device (“ısmarlama cihaz”) is a medical device made specifically according to the written prescription of an authorized person and intended to meet only the individual needs of a particular patient. Its other name in the legislation is “kişiye özel imal edilen cihaz” (device made specifically for an individual); in ÜTS it is registered as ITC (Ismarlama Tıbbi Cihaz, custom-made medical device).
This article gives the definition, the Annex XIII statement, the additional condition for class III implantable custom-made devices and the ITC registration fields in ÜTS as direct quotations from the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation) and the TİTCK ÜTS Kayıt Kılavuzu TCKKD-KLVZ-03 (the Agency’s ÜTS Registration Guide).
For ÜTS registration of your custom-made devices: Medical Device ÜTS Registration Consultancy
Contents
1. What Is a Custom-Made Device?
The definition is in Article 3, subparagraph (s) of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation):
“(s) Custom-made device (device made specifically for an individual): any device specifically made in accordance with a written prescription, drawn up by a person authorized under the Law No. 1219 of 11/4/1928 on the Procedures for the Practice of Medicine and Allied Arts by virtue of his or her professional qualifications, giving, under that person’s responsibility, specific design characteristics, and which is intended for the sole use of a particular patient exclusively to meet their individual condition and needs; mass-produced devices which need to be adapted to meet the specific requirements of any professional user, and devices which are mass-produced by means of industrial manufacturing processes in accordance with the written prescriptions of any authorized person, are not considered to be custom-made devices,”
The definition expressly excludes two groups:
Mass-produced devices which need to be adapted to meet the specific requirements of a professional user.
Mass-produced devices by means of industrial manufacturing processes, even where they comply with the written prescription of an authorized person.
For the short definition, see our page on what is a custom-made device.
2. CE Marking and the Statement Requirement
Article 21 of the Regulation:
“ARTICLE 21 - (1) With the exception of the devices referred to in Article 74, devices which do not bear the CE marking:”
“(b) custom-made devices made available on the market, provided that they comply with Article 52, paragraph 7 and Annex XIII,”
“shall not be prevented.”
“(2) Custom-made devices which are delivered to a specific patient or user identified by a name, an acronym or a numerical code shall be accompanied by the statement referred to in Section 1 of Annex XIII. The manufacturer of custom-made devices shall, on request, submit a list of such devices made available on the market to the Agency and, where applicable, to the competent authorities of the EU Member States in which the device is placed on the market.”
The device is accompanied by the Annex XIII statement. On request, the manufacturer submits to the Agency the list of custom-made devices it has made available on the market.
3. Conformity Assessment: Article 52
“(7) Manufacturers of custom-made devices shall follow the procedure set out in Annex XIII and draw up the statement set out in Section 1 of that Annex before placing such devices on the market. In addition to the procedure applicable under the first sentence, manufacturers of class III custom-made implantable devices shall be subject to a conformity assessment as specified in Chapter I of Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Part A of Annex XI.”
Article 52’s paragraphs on class III, IIb, IIa and I devices exclude custom-made devices. For class III implantable custom-made devices, Chapter I of Annex IX or Part A of Annex XI applies in addition to the Annex XIII procedure. For the choice of procedure, see our article on conformity assessment procedure selection.
4. What Does the Annex XIII Statement Contain?
“1. For custom-made devices, the manufacturer or its authorized representative shall draw up a statement containing all of the following information:”
“- the name and address of the manufacturer, and of all manufacturing sites,”
“- where applicable, the name and address of the authorized representative,”
“- data allowing the device in question to be identified,”
“- a statement that the device is intended for exclusive use by a particular patient or user, identified by name, an acronym or a numerical code,”
“- the name of the person who made out the prescription and who has been authorized by virtue of professional qualifications, and, where applicable, the name of the health institution concerned,”
“- the specific characteristics of the product as indicated by the prescription,”
“- a statement that the device in question conforms to the general safety and performance requirements set out in Annex I and, where applicable, indicating which general safety and performance requirements have not been fully met, with the reasons,”
The last item on the list is the indication that, where applicable, the device incorporates a medicinal substance, including a medicinal product derived from human blood or plasma, or tissues or cells of animal origin. The Annex XIII statement is a separate document from the EU declaration of conformity. For the EU declaration of conformity, see our article on EU declaration of conformity and CE marking.
5. Documentation, Retention Period and Vigilance
“2. The manufacturer undertakes to keep available for the Agency documentation which allows an understanding of the design, manufacture and performance of the device, including its expected performance, so as to allow assessment of conformity with the requirements of this Regulation, and which indicates the manufacturing site or sites.”
“4. The statement referred to in Section 1 of this Annex shall be kept for a period of at least 10 years after the device has been placed on the market. In the case of implantable devices, that period shall be at least 15 years.”
“5. The manufacturer shall review and document experience gained in the post-production phase, including from the post-market clinical follow-up as referred to in Part B of Annex XIV, and shall implement appropriate means to apply any necessary corrective action. In this context, it shall report, in accordance with Article 85, paragraph 1, to the competent authorities any serious incidents or field safety corrective actions or both, as soon as it becomes aware of them.”
For the person responsible for regulatory compliance of a custom-made device manufacturer, Article 15, subparagraph (c) requires at least two years of professional experience in the relevant field of manufacturing. Details are in our article on the person responsible for regulatory compliance.
6. Label Wording and the UDI Exemption
Section 23.2 of Annex I lists among the information to appear on the label:
“(m) if the device is a custom-made device, the words ‘custom-made device’,”
The UDI system does not cover custom-made devices:
“ARTICLE 27 -(1) The Unique Device Identification system (UDI system), established and controlled by the Commission and described in Part C of Annex VI, shall allow the identification of devices other than custom-made and investigational devices,”
The allocation of the Basic UDI-DI (Article 29) and the registration of actors in EUDAMED (Article 31) are also regulated for devices “other than custom-made devices”.
7. Who Registers an ITC in ÜTS?
Article 29 of the ÜTS Kayıt Kılavuzu (ÜTS Registration Guide) gives the ITC definition in the same way as the regulation and lists the types of firms that can apply:
“ARTICLE 29- (1) Firms or organizations of the types “Sağlık Hizmet Sunucusu” (Health Service Provider), “Üretici/ithalatçı/Bayi/İhracatçı” (Manufacturer/importer/dealer/exporter) and “Ismarlama Ortez-Protez Uygulama Merkezi” (Custom-made Orthosis-Prosthesis Application Center) in ÜTS can make an ITC application under the MDR.”
Under paragraph three of the same article, the ITC application for custom-made orthopedic prostheses and orthoses is made by the centers with the field of activity “Ismarlama Ortez-Protez Uygulama Merkezi” that produce them, or by the health institutions with the field of activity “Sağlık Hizmet Sunucusu” that have an orthosis-prosthesis manufacturing service within them. The application for other ITCs is made by the firms with the field of activity “Üretici/ithalatçı/Bayi/İhracatçı” that produce or import the ITC concerned. This second group can grant dealership to other firms through ÜTS; orthosis-prosthesis centers and health institutions cannot grant dealership (Article 29, paragraph four).
The Guide’s definition of custom-made orthosis-prosthesis:
“(s) Custom-made orthopedic prostheses and orthoses produced and/or applied: orthopedic prostheses and orthoses that are produced and/or must be applied with measurement and fitting, for use in a specific patient,”
8. The ÜTS ITC Registration Screen and the Statement
“(9) The information on the ÜTS registration screen that must be entered into the system during ITC registration under the MDR, and its explanations, are given under the headings “Tanımlayıcı Bilgiler” (Identifying Information), “İthal/İmal Bilgileri” (Import/Manufacture Information), “Beyan Bilgileri” (Statement Information), “Hasta ve Doktor/Diş Hekimi Bilgileri” (Patient and Doctor/Dentist Information), “Ürün Görselleri” (Product Images), “İçeriğindeki Tıbbi Cihazlar” (Medical Devices Contained), “Ölçü Bilgileri” (Measurement Information) and “Başvuru Durumu” (Application Status).”
The prominent rules of the Guide:
“5) If a primary product number has not been allocated for the ITC concerned by one of the authorized barcode organizations, the option “UTS” is selected in the relevant field. In this case, the primary product number for the ITC concerned is generated automatically by ÜTS with the prefix ‘UTS-’ (for example, UTS-12345).”
“2) If the firm/organization that issues the ITC Statement for the ITC mentioned in the fifth paragraph of this article is established in Türkiye, this field is selected as “İmal” (Manufactured). If the firm/organization that issues the ITC Statement is not located in Türkiye (a foreign manufacturer), this field is selected as “İthal” (Imported).”
“2) In this field, the specific characteristics (features) of the product are entered as indicated in the e-prescription or prescription/health report mentioned in the thirteenth paragraph of this article.”
If “İmal” (Manufactured) is selected:
“During the signing of the application, this statement file is signed with an e-signature by the responsible manager, the authorized signatory or the hospital officer of the firm/organization and sent with the application.”
If “İthal” (Imported) is selected:
Patient and doctor information:
Class III implantable: if the field “Sınıf-III implante edilebilir ısmarlama tıbbi cihaz mı?” (Is it a class III implantable custom-made medical device?) is set to “Evet” (Yes), the relevant fields open and the EU Certificate of the registered document type “AB Sertifikası (MDR/IVDR)” (EU Certificate (MDR/IVDR)) is selected or, if an EBS application has been made under 2023/KK-1, the supporting documents are uploaded (twelfth paragraph, subparagraphs ç-f). For registering the certificate in ÜTS, see our article on ÜTS document registration .
Medical devices contained: if a medical device was used in creating the final product, these devices are selected from the “Üreticisi Olunan Ürün Ekle” (Add Product I Manufacture) or “Bayisi Olunan Ürün Ekle” (Add Product I Am Dealer For) screens. If a device that is not in “Kayıtlı” (Registered) status is selected, ÜTS automatically blocks the ITC application (fifteenth paragraph).
After registration is completed, “Ismarlama Tıbbi Cihaz Başvurusu” (Custom-made Medical Device Application) is selected as the device application type. For general product registration, see our article on ÜTS product registration.
9. Frequently Asked Questions
Is a mass-produced device whose size is selected for the patient considered a custom-made device?
No. Article 3, subparagraph (s) excludes from the definition mass-produced devices that need to be adapted to the specific requirements of the professional user, and devices mass-produced by industrial manufacturing processes even where they comply with the prescription.
Does a custom-made device bear the CE marking?
Under Article 21, the making available on the market of custom-made devices that do not bear the CE marking is not prevented, provided that they comply with Article 52, paragraph 7 and Annex XIII.
How long is the Annex XIII statement kept?
Under Section 4 of Annex XIII, at least 10 years after placing on the market; at least 15 years for implantable devices.
How is ÜTS registration done if a custom-made device has no barcode?
“UTS” is selected in the “Birincil Barkod Kuruluşu” (Primary Barcode Organization) field. The primary product number is generated automatically by ÜTS with the prefix “UTS-” and cannot be changed by the firm.
Does a domestic manufacturer upload the ITC statement to ÜTS?
No. For an ITC with “İmal” (Manufactured) selected, the statement is generated automatically by ÜTS from the information entered and is signed with an e-signature during application signing. For a foreign manufacturer (“İthal”, Imported), the original statement is uploaded.
For ÜTS ITC registration of your custom-made devices: Medical Device ÜTS Registration Consultancy
Sources



